Analysis of Drug Resistance in Pathogenic Fungi

Medical Mycology: Cellular and Molecular Techniques

Volumn , Issue , 2007, Pages 93-113

  Moran, Gary P ^a   Pinjon, Emmanuelle ^a   Coleman, David C ^a   Sullivan, Derek J ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Caspofungin first antifungal drug; Minimum inhibitory concentrations (MICs); Multidrug transporters in pathogenic fungi; Pathogenic fungi drug resistance analysis; Qualitative detection of alterations in membrane sterol contents; Rhodamine 6G uptake and glucose induced efflux

Indexed keywords

EID: 84879461856     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470057414.ch5     Document Type: Chapter

References (42)

1. Al Mosaid, A., Sullivan, D. J., Polacheck, I., Shaheen, F. A. et al. (2005) Novel 5-Flucytosine-Resistant Clade of Candida dubliniensis from Saudi Arabia and Egypt identified by Cd25 fingerprinting. J. Clin. Microbiol. 43: 4026-4036.
2. Canton, E., Peman, J., Carrillo-Munoz, A., Orero, A. et al. (1999) Fluconazole susceptibilities of bloodstreamCandidasp. isolatesasdeterminedbyNationalCommitteeforClinicalLaboratory Standards method M27-A and two other methods. J. Clin. Microbiol. 37: 2197-2200.
3. Cuenca-Estrella, M., Moore, C. B., Barchiesi, F. et al. (2003) Multicenter evaluation of the reproducibility of the proposed antifungal susceptibility testing method for fermentative yeasts of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST). Clin. Infect. Dis. 9: 467-474.
4. Diaz-Guerra, T. M., Mellado, E., Cuenta-Estrella, M. and Rodriguez-Tudela, J. L. (2003) A point mutation in the 14alpha-sterol demethylase gene Cyp51A contributes to itraconazole resistance in Aspergillus fumigatus. Antimicrob. Agents Chemother. 47: 1120-1124.
5. Dodgson, A. R., Dodgson, K. J., Pujol, C., Pfaller, M. A. and Soll, D. R. (2004) Clade-specific flucytosine resistance is due to a single nucleotide change in the FUR1 gene of Candida albicans. Antimicrob. Agents Chemother. 48: 2223-2227.
6. Espinel-Ingroff, A., Chaturvedi, V., Fothergill, A.W. and Rinaldi, M. G. (2002) Optimal testing conditions for determining MICs and minimum fungicidal concentrations of new and established antifungal agents for uncommon molds: NCCLS collaborative study. J. Clin. Microbiol. 40: 3776-3781.
7. Fridkin, S. K. and Jarvis, W. R. (1996) Epidemiology of nosocomial fungal infections. Clin. Microbiol. Rev. 9: 499-511.
8. Gil-Lamaignere, C. and Muller, F. M. (2004) Differential effects of the combination of caspofungin and terbinafine against Candida albicans, Candida dubliniensis and Candida kefyr. Int. J. Antimicrob. Agents 23: 520-523.
9. Groll, A. H., De Lucca, A. J. and Walsh, T. J. (1998) Emerging targets for the development of novel antifungal therapeutics. Trends Microbiol. 6: 117-124.
10. Hope,W.W., Tabernero, L., Denning, D.W. and Anderson, M. J. (2004) Molecular mechanisms of primary resistance to flucytosine in Candida albicans. Antimicrob. Agents Chemother. 48: 4377-4386.
11. Johnson, E. M., Warnock, D. W., Luker, J., Porter, S. R. and Scully, C. (1995) Emergence of azole drug resistance in Candida species from HIV-infected patients receiving prolonged fluconazole therapy for oral candidosis. Antimicrob. Agents Chemother. 35: 103-114.
12. Kaplan, J. E., Hanson, D., Dworkin, M. S., Frederick, T. et al. (2000) Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy. Clin. Infect. Dis. 30(suppl 1), S5-14.
13. Kelly, S. L., Lamb, D. C., Corran, A. J., Baldwin, B. C. and Kelly, D. E. (1995) Mode of action and resistance to azole antifungals associated with the formation of 14a-methylergosta-8,24(28)-dien-3B,6a-diol Biochem. Biophys. Res. Commun. 207: 910-915.
14. Krcmery, V. and Barnes, A. J. (2002) Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance. J. Hosp. Infect. 50: 243-260.
15. Leenders, A. C., de Marie, S., ten Kate, M. T., Bakker-Woudenberg, I. A. and Verbrugh, H. A. (1996) Liposomal amphotericin B (AmBisome) reduces dissemination of infection as compared with amphotericin B deoxycholate (Fungizone) in a rate model of pulmonary aspergillosis. J. Antimicrob. Chemother. 38: 215-225.
16. Maesaki, S., Marichal, P., Vanden Bossche, H., Sanglard, D. and Kohno, S. (1999) Rhodamine 6G efflux for the detection of CDR1-overexpressing azole-resistant Candida albicans strains. J. Antimicrob. Chemother. 44: 27-31.
17. Mellado, E., Garcia-Effron, G., Alcazar-Fuoli, L., Cuenta-Estrella, M. and Rodriguez-Tudela, J. L. (2004) Substitutions at methionine 220 in the 14alpha-sterol demethylase (Cyp51A) of Aspergillus fumigatus are responsible for resistance in vitro to azole antifungal drugs. Antimicrob. Agents Chemother. 48: 2747-2750.
18. Moore, C. B., Sayers, N., Mosquera, J., Slaven, J. and Denning, D. W. (2000) Antifungal drug resistance in Aspergillus. J. Infect. 41: 203-220.
19. Moran, G. P., Sullivan, D. J., Henman, M. C., McCreary, C. E. et al. (1997) Antifungal drug susceptibilities of oral Candida dubliniensis isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected subjects and generation of stable fluconazole-resistant derivatives in vitro. Antimicrob. Agents Chemother. 41: 617-623.
20. Moran, G. P., Sanglard, D., Donnelly, S. M., Shanley, D. B. et al. (1998) Identification and expression of multidrug transporters responsible for fluconazole resistance in Candida dubliniensis. Antimicrob. Agents Chemother. 42: 1819-1830.
21. Mosquera, J. and Denning, D. W. (2002) Azole cross-resistance in Aspergillus fumigatus. Antimicrob. Agents Chemother. 46: 556-557.
22. Muller, F-M. C., Weig, M., Peter, J. and Walsh, T. J. (2000) Azole cross-resistance to ketoconazole, fluconazole, itraconazole and voriconazole in clinical Candida albicans isolates from HIV-infected children with oropharyngeal candidosis. J. Antimicrob. Chemother. 46: 323-342.
23. Nascimento, A. M., Goldman, G. H., Park, S. et al. (2003) Multiple resistance mechanisms among Aspergillus fumigatus mutants with high-level resistance to itraconazole. Antimicrob. Agents Chemother. 47: 1719-1726.
24. Pfaller, M. A., Diekema, D. J., Messer, S. A., Boyken, L. et al. (2003a) In vitro activities of voriconazole, posaconazole, and four licensed systemic antifungal agents against Candida species infrequently isolated from blood. J. Clin. Microbiol. 41: 78-83.
25. Pfaller, M. A., Messer, S. A., Boyken, L., Rice, C. et al. (2003b) Caspofungin activity against clinical isolates of fluconazole-resistant Candida. J. Clin. Microbiol. 41: 5729-5731.
26. Pfaller, M. A. and Diekema, D. J. (2004) Twelve years of fluconazole in clinical practice: Global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida. Clin. Microbiol. Infect. 10 Suppl 1, 11-23.
27. Pinjon, E., Moran, G. P., Jackson, C. J., Kelly, S. L. et al. (2003) Molecular mechanisms of itraconazole resistance in Candida dubliniensis. Antimicrob. Agents Chemother. 47: 2424-2437.
28. Powderly, W. G. (1992) Mucosal candidiasis caused by non-albicans species of Candida in HIV-positive patients AIDS 6: 604-605.
29. Rex, J. H., Cooper, C. R., Merz, W. G., Galgiani, J. N. and Anaissie, E. J. (1995) Detection of amphotericin B-resistant Candida isolates in a broth based system. Antimicrob. Agents Chemother. 39: 906-909.
30. Rodero, L., Mellado, E., Rodriguez, A. C., Salve, A. et al. (2003) G484S amino acid substitution in lanosterol 14-alpha demethylase (ERG11) is related to fluconazole resistance in a recurrent Cryptococcus neoformans clinical isolate. Antimicrob. Agents Chemother. 47: 3653-3656.
31. Saag, M. S. and Dismukes, W. E. (1988) Azole antifungal agents: Emphasis on new triazoles. Antimicrob. Agents Chemother. 23: 1-8.
32. Sanglard, D., Kuchler, K., Ischer, F., Pagani, J.-L. et al. (1995) Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters. Antimicrob. Agents Chemother. 39: 2378-2386.
33. Sanglard, D., Ischer, F., Monod, M. and Bille, J. (1997) Cloning of Candida albicans genes conferring resistance to azole antifungal agents: Characterisation of CDR2, a new multidrug ABC transporter gene Microbiol. 143: 405-416.
34. Sanglard, D., Ischer, F., Koymans, L. and Bille, J. (1998) Amino acid substitutions in the cytochrome P-450 lanosterol 14a-demethylase (CYP51A1) from azole-resistant Candida albicans clinical isolates contribute to resistance to azole antifungal agents. Antimicrob. Agents Chemother. 42: 241-253.
35. Sanglard, D., Ischer, F., Calabrese, D., Majcherczyk, P. A. and Bille, J. (1999) The ATP binding cassette transporter gene CgCDR1 from Candida glabrata is involved in the resistance of clinical isolates to azole antifungal agents. Antimicrob. Agents Chemother. 43: 2753-2765.
36. Sanguinetti, M., Posteraro, B., Fiori, B., Ranno, S. et al. (2005) Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance. Antimicrob. Agents Chemother. 49: 668-679.
37. Sullivan, D., Haynes, K., Moran, G., Shanley, D. and Coleman, D. (1996) Persistence, replacement, and microevolution of Cryptococcus neoformans strains in recurrent meningitis in AIDS patients. J. Clin. Microbiol. 34: 1739-1744.
38. VandenBergh, M. F., Verweij, P. E. and Voss, A. (1999) Epidemiology of nosocomial fungal infections: invasive aspergillosis and the environment. Diagn. Microbiol. Infect. Dis. 34: 221-227.
39. White, T. C. (1997) The presence of an R467K amino acid substitution and loss of allelic variation correlate with an azole-resistant lanosterol 14a demethylase in Candida albicans. Antimicrob. Agents Chemother. 41: 1488-1494.
40. White, T. C., Marr, K. A. and Bowden, R. A. (1998) Clinical, cellular, and molecular factors that contribute to antifungal drug resistance Clin. Microbiol. Rev. 11: 382-402.
41. Willocks, L., Leen, C. L. S., Brettle, R. P., Urquhart, D. et al. (1991) Fluconazole resistance in AIDS patients. J. Antimicrob. Chemother. 28: 937-939.
42. Xu, J., Ramos, A. R., Vilgalys, R. and Mitchell, T. G. (2000) Clonal and spontaneous origins of fluconazole resistance in Candida albicans. J. Clin. Microbiol. 38: 1214-1220.